FDA perspective on clinical trial design for cardiovascular devices

被引：22

作者：

Chen, Eric ^{[1
]}

Sapirstein, Wolf ^{[1
]}

Ahn, Chul ^{[1
]}

Swain, Julie ^{[1
]}

Zuckerman, Bram ^{[1
]}

机构：

[1] US FDA, Ctr Devices & Radiol Hlth, Off Device Evaluat, Rockville, MD 20850 USA

来源：

ANNALS OF THORACIC SURGERY | 2006年 / 82卷 / 03期

关键词：

D O I：

10.1016/j.athoracsur.2006.07.044

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：773 / 775

页数：3

共 7 条

[1] Prosthetic heart valves: Objective performance criteria versus randomized clinical trial [J].

Grunkemeier, Gary L. ;

Jin, Ruyun ;

Starr, Albert .

ANNALS OF THORACIC SURGERY, 2006, 82 (03) :776-780

[2] Progress versus precision: Challenges in clinical trial design for left ventricular assist devices [J].

Parides, Michael K. ;

Moskowitz, Alan J. ;

Ascheim, Deborah D. ;

Rose, Eric A. ;

Gelijns, Annetine C. .

ANNALS OF THORACIC SURGERY, 2006, 82 (03) :1140-1146

[3] Long-term use of a left ventricular assist device for end-stage heart failure [J].

Rose, EA ;

Gelijns, AC ;

Moskowitz, AJ ;

Heitjan, DF ;

Stevenson, LW ;

Dembitsky, W ;

Long, JW ;

Ascheim, DD ;

Tierney, AR ;

Levitan, RG ;

Watson, JT ;

Meier, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20) :1435-1443

[4]

FED REG, V43, P32988

[5]

2006, INTERAGENCY REGISTRY

[6]

1998, FED REG, V63, P64617

[7]

2006, FDA BAYESIAN DRAFT G

← 1 →